Open AccessHeparin Cryoprecipitation Reduces Plasma Levels of Non-Traditional Risk Factors for Atherosclerosis in vitro
Author(s) -
Edna Meilin,
Shifra Sela,
Batya Kristal
Publication year - 2008
Publication title -
blood purification
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.686
H-Index - 57
eISSN - 1421-9735
pISSN - 0253-5068
DOI - 10.1159/000119543
Subject(s) - fibrinogen , albumin , chemistry , in vivo , in vitro , heparin , blood proteins , serum albumin , hemodialysis , medicine , pharmacology , immunology , biochemistry , biology , microbiology and biotechnology
To show that heparin cryoprecipitation (HCP), an in vitro method of plasma purification, reduces the levels of in vivo modified proteins and non-traditional risk factors from plasma of atherosclerotic hemodialysis (HD) patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom